-+ 0.00%
-+ 0.00%
-+ 0.00%

Precision BioSciences Announces 2026 Strategic Plan Focused on Advancing Clinical-Stage PBGENE-HBV and PBGENE-DMD Programs, Initiating DMD Clinical Trials, and Maintaining Cash Runway Through 2028

Reuters·01/12/2026 12:02:31

Please log in to view news